Patents by Inventor Tara L. Crowder

Tara L. Crowder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220323019
    Abstract: A clinical response estimate (CRE) biomarker of a patient having an implanted neurostimulation system is monitored. To this end, an input dataset is derived from a subject-patient dataset that includes various different data types and different features of the patient. The data types are based on electrical activity the patient's brain sensed and stored by the implanted neurostimulation system. The input dataset is a subset of the larger subject-patient dataset, and the specific data types and patient features included in that subset are derived based on a plurality of key inputs of the subject-patient dataset. Once the input dataset is derived, it is processed by a clinical response estimator having machine-learned models. First and second machine-learned models of the clinical response estimator are applied to the input dataset to provide model inputs to an ensemble machine-learned model to determine the CRE biomarker.
    Type: Application
    Filed: March 30, 2022
    Publication date: October 13, 2022
    Inventors: Sharanya Arcot Desai, Tara L. Crowder, Thomas K. Tcheng, Martha J. Morrell, Lise Johnson Dyhr
  • Publication number: 20220313159
    Abstract: An input dataset is processed to obtain a pre-event window of model inputs and a post-event window of model inputs. The input dataset is a subset of a larger subject-patient dataset that includes different data types and features of the patient. The data types are based on electrical activity of the patient's brain that is sensed and stored by an implanted neurostimulation system. A clinical response estimator (CRE) model is applied to the pre-event window of model inputs to derive pre-event CRE biomarkers. The CRE model is also applied to the post-event window of model inputs to derive post-event CRE biomarkers. The pre-event CRE biomarkers and post-event CRE biomarkers are displayed as a function of time together with the occurrence of the event of interest.
    Type: Application
    Filed: March 30, 2022
    Publication date: October 6, 2022
    Inventors: Sharanya Arcot Desai, Tara L. Crowder, Thomas K. Tcheng, Martha J. Morrell, Lise Johnson Dyhr
  • Publication number: 20210298654
    Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
    Type: Application
    Filed: June 14, 2021
    Publication date: September 30, 2021
    Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng
  • Patent number: 11064926
    Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: July 20, 2021
    Assignee: NeuroPace, Inc.
    Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng
  • Publication number: 20180085015
    Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
    Type: Application
    Filed: November 17, 2017
    Publication date: March 29, 2018
    Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng
  • Publication number: 20130172774
    Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
    Type: Application
    Filed: June 30, 2012
    Publication date: July 4, 2013
    Applicant: NEUROPACE, INC.
    Inventors: Tara L. Crowder, Brett M. Wingeier, Martha J. Morrell, Felice Sun, Thomas Tcheng